Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
| ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
|---|---|---|---|---|---|
| 11.003.079 | Invasive Prenatal (Fetal) Diagnostic Testing | Sep 05, 2025 | Sep 20, 2026 | Invasive prenatal (fetal) diagnostic testing may be used to identify pathogenic genetic alterations in... | Ver |
| 11.003.081 | Genetic Testing For Macular Degeneration | Apr 22, 2025 | Apr 20, 2026 | Age-related macular degeneration is a complex disease involving both genetic and environmental influences.... | Ver |
| 11.003.082 | Genetic Testing For Facioscapulohumeral Muscular Dystrophy | Mar 12, 2025 | Mar 20, 2026 | Facioscapulohumeral muscular dystrophy (fshd) is an autosomal dominant disease that typically presents before... | Ver |
| 11.003.083 | Genetic Testing For Charge Syndrome | Mar 12, 2025 | Mar 20, 2026 | Charge syndrome is a rare genetic condition associated with multiple congenital anomalies. in many... | Ver |
| 11.003.084 | Genetic Testing For Idiopathic Dilated Cardiomyopathy | Mar 12, 2025 | Mar 20, 2026 | Dilated cardiomyopathy (dcm) is characterized by progressive left ventricular enlargement and systolic... | Ver |
| 11.003.085 | Genetic Testing For Limb-Girdle Muscular Dystrophies | Jun 18, 2024 | Policy Archived | ... | Ver |
| 11.003.086 | Kif6 Genotyping For Predicting Cardiovascular Risk | Aug 20, 2021 | Policy Archived | Genetic testing to determine kinesin-like protein 6 (kif6) trp719arg variant status is being evaluated as a... | Ver |
| 11.003.087 | Molecular Testing In The Management Of Pulmonary Nodules | Jun 18, 2024 | Jun 20, 2025 | Plasma-based proteomic screening and gene expression profiling of bronchial brushing are molecular tests... | Ver |
| 11.003.088 | Molecular Testing For Chronic Heart Failure And Heart Transplant | Jun 17, 2021 | Policy Archived | Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... | Ver |
| 11.003.089 | Circulating Tumor Dna And Circulating Tumor Cells For Cancer Management (Liquid Biopsy) | Sep 20, 2024 | Sep 20, 2025 | Circulating tumor dna (ctdna) and circulating tumor cells (ctcs) in peripheral blood, referred to as... | Ver |
| 11.003.090 | Gene Expression Profiling For Uveal Melanoma | Mar 12, 2025 | Mar 20, 2026 | Uveal melanoma is associated with a high rate of metastatic disease, and survival after the development of... | Ver |
| 11.003.092 | Proteogenomic Testing For Patients With Cancer | Jul 11, 2025 | Jul 20, 2026 | Proteogenomics refers to the integration of genomic information with proteomic and transcriptomic information... | Ver |
| 11.003.093 | Genetic Testing For Mitochondrial Disorders | Oct 08, 2024 | Oct 20, 2025 | Mitochondrial diseases are multisystem diseases that arise from dysfunction in the mitochondrial protein... | Ver |
| 11.003.094 | Serum Biomarket Panel Testing For Systemic Lupus Erythematosus And Other Connective Tissue Deseases | Jul 11, 2025 | Jul 20, 2026 | Systemic lupus erythematosus (sle) is an autoimmune connective tissue disease (ctd) that can be difficult to... | Ver |
| 11.003.095 | Genotype-Guided Tamoxifen Treatment | Sep 13, 2024 | Sep 20, 2025 | Tamoxifen is prescribed as a component of adjuvant endocrine therapy to prevent endocrine receptor-positive... | Ver |
| 11.003.096 | Miscellaneous Genetic And Molecular Diagnostic Tests | Aug 12, 2024 | Aug 20, 2025 | There are numerous commercially available genetic and molecular diagnostic, prognostic, and therapeutic tests... | Ver |
| 11.003.097 | Gene Expression Profiling For Cutaneous Melanoma | Jun 09, 2025 | Jun 20, 2026 | Laboratory tests have been developed that detect the expression of different genes in pigmented lesions or... | Ver |
| 11.003.098 | Use Of Common Genetic Variants (Single Nucleotide Variants) To Predict Risk Of Nonfamilial Breast Cancer | Nov 15, 2024 | Nov 20, 2025 | Several single nucleotide variants (snvs), which are single base-pair variations in the dna sequence of the... | Ver |
| 11.003.099 | Circulating Tumor Dna For Management Of Non-Small-Cell Lung Cancer (Liquid Biopsy) | Dec 10, 2021 | Policy Archived | ... | Ver |
| 11.003.100 | Dna-Based Testing For Adolescent Idiopathic Scoliosis | Mar 05, 2021 | Policy Archived | Adolescent idiopathic scoliosis (ais) is a disease of unknown etiology that causes mild-to-severe spinal... | Ver |
